|
|
|
|
|
BioCision
|
http://www.biocision.com/
|
|
|
BioT ULT Transporter
|
|
The growth of biobanking, cell therapy, and complex biopharmaceutical
therapies like cancer vaccines has created a strong need for products
and processes to ensure the stability of temperature-sensitive
biospecimens. Proper collection, handling, characterization, packaging
and shipping of these materials is critical, as poor sample handling
impacts researchers working on discovery with patient samples, as well
as clinicians treating patients with cutting edge therapies.
This
white paper describes in detail the BioCision BioT™ ULT Transporter,
the first-of-its-kind dry ice-based portable cooling system that
maintains a stable -75° to -50°C environment for over 24 hours on one
charge of dry ice, enabling reliable handling and transfer of valuable
temperature-sensitive biospecimens as part of a larger cold chain
standardization process.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
PHASTAR Names Chris Schoonmaker as Chief Operations Officer
More info >> |
|
 |
White Papers |
 |
|
pAVEway™ expression system for the efficient expression of therapeutic proteins
Fujifilm Diosynth Biotechnologies
One of the major bottlenecks in the production of biopharmaceuticals is
the efficient expression of therapeutic proteins in microbial or
mammalian cells. The Escherichia coli pAVEway™ expression system
described here has been developed to ensure high product titres and
efficient scale up to GMP manufacture, whilst minimising many common
issues seen in other expression systems, such as ‘leaky’ expression
(expression of recombinant protein in the absence of inducer).
More info >> |
|
 |
Industry Events |
 |
Connect in Pharma
14-15 September 2022, Plaexpo, Geneva, Switzerland
The new event driving innovation for pharma and biopharma businesses,
Connect in Pharma will unite key players in Pharmaceutical and
Biopharmaceutical packaging and production in Geneva on 14 – 15
September 2022.
More info >> |
|
|
|
